Zheng Quan Zhi Xing·2025-08-15 16:35General Information - Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was established on September 1, 1997, and is registered in Guangzhou, China [1] - The company was approved to issue 219,900,000 shares to foreign investors and listed on the Hong Kong Stock Exchange in October 1997 [1] - The company later issued 78,000,000 shares to the public and was listed on the Shanghai Stock Exchange in February 2001 [1] Company Structure - The company is a permanent joint-stock company and operates under the laws of the People's Republic of China [3] - The legal representative of the company is elected by the board of directors and must be determined within 30 days of any resignation [2][3] - The company has established a Chinese Communist Party organization to play a political core role [3] Business Objectives and Scope - The company's business objective is to implement new development concepts, serve national strategies, and focus on innovation-driven development [4] - The business scope includes drug research and development, manufacturing of chemical drugs, traditional Chinese medicine, and various health-related products [4][5] Share Capital and Structure - The registered capital of the company is RMB 1,625,790,949 [8] - The share structure includes state shares, foreign shares, and domestic shares, with the largest shareholder being Guangzhou Pharmaceutical Group Co., Ltd. [7][8] - The company has issued a total of 1,625,790,949 shares, with the following distribution: 45.04% held by the state, 13.53% by foreign investors, and 41.43% by domestic investors [8] Shareholder Rights and Obligations - Shareholders have the right to request meetings, receive dividends, supervise company operations, and access company documents [16][39] - Shareholders are obligated to comply with laws and regulations, pay for their subscribed shares, and not abuse their rights to harm the company or other shareholders [45][46] Governance and Decision-Making - The company’s governance structure includes a board of directors and a shareholder meeting, which is the highest authority [50] - Major decisions, such as capital increases, mergers, and financial guarantees, require approval from the shareholder meeting [24][26] - The company must hold an annual shareholder meeting within six months after the end of the fiscal year [56]